首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1528篇
  免费   82篇
财政金融   310篇
工业经济   128篇
计划管理   229篇
经济学   268篇
综合类   54篇
运输经济   20篇
旅游经济   47篇
贸易经济   404篇
农业经济   50篇
经济概况   100篇
  2023年   5篇
  2022年   10篇
  2021年   14篇
  2020年   20篇
  2019年   41篇
  2018年   40篇
  2017年   49篇
  2016年   39篇
  2015年   43篇
  2014年   36篇
  2013年   211篇
  2012年   52篇
  2011年   45篇
  2010年   61篇
  2009年   66篇
  2008年   67篇
  2007年   50篇
  2006年   64篇
  2005年   56篇
  2004年   51篇
  2003年   54篇
  2002年   67篇
  2001年   36篇
  2000年   36篇
  1999年   31篇
  1998年   43篇
  1997年   30篇
  1996年   19篇
  1995年   26篇
  1994年   22篇
  1993年   17篇
  1992年   22篇
  1991年   21篇
  1990年   15篇
  1989年   15篇
  1988年   8篇
  1987年   7篇
  1986年   11篇
  1985年   18篇
  1984年   13篇
  1983年   7篇
  1982年   11篇
  1981年   7篇
  1980年   10篇
  1979年   9篇
  1978年   6篇
  1977年   5篇
  1976年   7篇
  1974年   4篇
  1964年   3篇
排序方式: 共有1610条查询结果,搜索用时 0 毫秒
131.
Objective:

To identify cost estimates related to myocardial infarction (MI) or stroke in patients with type 2 diabetes mellitus (T2DM) for use in economic models.

Methods:

A systematic literature review was conducted. Electronic databases and conference abstracts were screened against inclusion criteria, which included studies performed in patients who had T2DM before experiencing an MI or stroke. Primary cost studies and economic models were included. Costs were converted to 2012 pounds sterling.

Results:

Fifty-four studies were identified: 13 primary cost studies and 41 economic evaluations using secondary sources for complication costs. Primary studies provided costs from 10 countries. Estimates for a fatal event ranged from £2482–£5222 for MI and from £4900–£6694 for stroke. Costs for the year a non-fatal event occurred ranged from £5071–£29,249 for MI and from £5171–£38,732 for stroke. Annual follow-up costs ranged from £945–£1616 for an MI and from £4704–£12,926 for a stroke. Economic evaluations from 12 countries were identified, and costs of complications showed similar variability to the primary studies.

Discussion:

The costs identified within primary studies varied between and within countries. Many studies used costs estimated in studies not specific to patients with T2DM. Data gaps included a detailed breakdown of resource use, which affected the ability to compare data across countries.

Conclusions:

In the development of economic models for patients with T2DM, the use of accurate estimates of costs associated with MI and stroke is important. When country-specific costs are not available, clear justification for the choice of estimates should be provided.  相似文献   

132.
133.
134.
135.
New, techniques of international patent anabsis are illustrated and resultsfrom preliminary validity tests of these techniques are presented. Indicators of technological activity, technological significance and commercial potential are constructed, and used to analyze fiber-based opto-electronic couplers and monoclonal-antibody-based diagnostic kits at the levels o f the technology, nation and firm. The international patent indicators are found to be closely correlated with R&D expenditures, scientific publications and new product introductions. They also relate to these indicators in ways that moke sense as specified in simple regression models of the innovation process. Comparisons of patent analysis results with expert opinion (for two process technologies) reveal that technology–level analyzes conform quite well with expert opinion, but national – and firm–level analyes vary from a low to a modest correlation with expert opinion. The authors conclude that the techniques can provide important information for corporate technology management, but that studies of additional technologies and further validity tests are needed.  相似文献   
136.
This paper focuses on potential reasons for variations in benefit packages, in particular variations in the availability of retirement health insurance and leave. An important feature of our analysis is that we do not start with heterogeneity in workforces to explain fringe benefit differences across employers. It would be straightforward to say that differences across employers in fringe benefit packages simply represent differences in the preferences of their workforces. Rather, we focus on heterogeneity across employers as an important source of differences in fringe benefit packages. Preliminary evidence is found supportive of the predicted differences in the likelihood of such fringe benefits as retirement health insurance and leave based upon two variables–the extent of on-the-job training offered by the employer and the size of the employers. We also examine the implied links between these fringe benefits and such variables as average tenture and the proportion of the workforce that is female.  相似文献   
137.
138.
139.
Abstract

The importance of increased levels of education in improving the status of women throughout the world is well established. Higher levels of education are associated with lower birth rates, higher incomes, and greater autonomy for women. Yet, women's struggle to have a voice in higher education has been fraught with difficulties in the US and worldwide, particularly in overcoming widely held perceptions that limit their entrance into certain academic fields, tenured positions, and elite universities. This essay examines the role political economy has played in providing narratives that rationalize women's limited participation in higher education. By examining the representation of women in the academic culture of the nineteenth- and twentieth-century US, we can perhaps better understand women's struggle to obtain an authoritative voice in higher education worldwide.  相似文献   
140.
Mental disorders exact a heavier toll on workplace productivity than do physical illnesses, but a complete behavioral health program is often looked upon as just one more driver of rate increases. Properly understood, promoted and utilized, however, behavioral health benefits can contribute to decreased absenteeism and increased productivity, and even help offset the treatment costs of medical disorders.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号